Achieving ultra-high purity (≥99.9%) in peptide synthesis requires advanced purification techniques and rigorous quality control. While ≥98% purity is sufficient for most research applications, certain applications—including structural studies, in vivo experiments, and clinical development—demand the highest possible purity.
Ultra-high purity is achieved through multiple rounds of preparative HPLC purification, often combined with additional steps such as ion exchange chromatography or size exclusion chromatography. Each purification step removes impurities but also reduces yield, making the process both time-consuming and costly.
Key factors in achieving ultra-high purity include the quality of the crude peptide, the selectivity of the purification method, and the skill of the purification team. High-quality crude peptide with fewer impurities requires less purification to achieve target purity. Selective purification methods that effectively separate the target peptide from closely related impurities are essential. Experienced purification chemists who can optimize conditions for each peptide are critical for success.
Applications requiring ultra-high purity include NMR spectroscopy and X-ray crystallography, where even minor impurities can interfere with data interpretation. In vivo studies where impurities may cause off-target effects also benefit from ultra-high purity. Clinical development requires rigorous impurity characterization and control, with specifications often requiring ≥99% purity.
At PeptideHub, we offer ultra-high purity synthesis for demanding applications. Our advanced purification systems and experienced operators deliver this level of purity for challenging projects, with fully documented processes. We work closely with customers to define appropriate purity specifications for their specific applications, balancing quality requirements with cost considerations.